Capsaicin Cream

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Capsaicin Cream
Generic name: CAPSAICIN
Manufacturer: Trifecta Pharmaceuticals USA LLC
Product type: HUMAN OTC DRUG
SPL set ID: def8d341-06a7-0e9b-e053-2995a90a0ad6
SPL ID: 292a33db-d5ab-982c-e063-6394a90aa127
Version: 4
Effective date: 2024-12-13
Source export date: 2026-10-27
Source partition: 4
Source file: https://download.open.fda.gov/drug/label/drug-label-0004-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-10-27/a758d73d4d838a965005e6adf01b928e2da86f99be0f8bbaeeb95f3b7acbe418/drug-label-0004-of-0014.json.zip
Source manifest SHA-256: 6be3667a3beefe6c0ead4c723ea963050533a2bc725a8044d58b07d18b258c55
Import run: 20261027T193451Z
Imported at: 2026-10-27 19:57:04

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 11 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M017	openfda.application_number
brand name		Capsaicin Cream	openfda.brand_name
generic name		CAPSAICIN	openfda.generic_name
manufacturer name		Trifecta Pharmaceuticals USA LLC	openfda.manufacturer_name
ndc	package	69396-103-02	openfda.package_ndc
ndc	product	69396-103	openfda.product_ndc
ndc11	package	69396010302	derived:openfda.package_ndc
rxcui		646333	openfda.rxcui
spl id		292a33db-d5ab-982c-e063-6394a90aa127	id
spl set id		def8d341-06a7-0e9b-e053-2995a90a0ad6	set_id
unii		S07O44R1ZM	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings For external use only: TEST FIRST ON SMALL AREA OF SKIN. When using this product: Use only as directed Do not apply to wounds, damaged, broken or irritated skin Avoid contact with the eyes or mucous membranes A slight burning sensation may occur upon application, but generally disappears after several days If severe burning occurs, discontinue use Do not expose the treated area to heat or direct sunlight Do not bandage Do not use with heating pad Do not use at the same time as other topical analgesics

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.